Washington: Scientists have developed a chemical compound that they say can prevent infection caused by the SARS-CoV-2 virus. He has claimed that the severity of Kovid-19 (COVID-19) can be reduced if it is given early during infection.
According to researchers at Washington University School of Medicine in the US, a compound called ‘MM3122’ weakens them by interfering with a key feature of many viruses attacking human cells.
The compound, reported in the journal Proceedings of the National Academy of Sciences, targets transmembrane serine protease 2 (TMPRSS2), a key protein found in humans, which is also used by the coronavirus to enter and kill human cells. To infect.
The compound will prevent the virus from entering cells
Study author James W. Janetka, a professor at the University of Washington, said: “While many anti-SARS-CoV-2 vaccines now exist, there is still a need for effective ‘antiviral’ drugs to reduce the severity of this global pandemic.” He said, ‘The chemical compound we are developing will prevent the virus from entering the cells.’
Janetka said the goal of the study is to develop the molecules into an inhibitor that can be taken by mouth and could become an effective part of anti-Covid-19 drug inhibitors. Washington University made a special chemical, claims to protect against SARS as well as Corona
Washington: Scientists have developed a chemical compound that they say can prevent infection caused by the SARS-CoV-2 virus. He has claimed that the severity of Covid-19 (COVID-19) can be reduced if it is given early during infection.
According to researchers at Washington University School of Medicine in the US, a compound called ‘MM3122’ weakens them by interfering with a key feature of many viruses attacking human cells.
The compound, reported in the journal Proceedings of the National Academy of Sciences, targets transmembrane serine protease 2 (TMPRSS2), a key protein found in humans, which is also used by the coronavirus to enter and kill human cells. To infect.
The compound will prevent the virus from entering cells
Study author James W. Janetka, a professor at the University of Washington, said: “While many anti-SARS-CoV-2 vaccines now exist, there is still a need for effective ‘antiviral’ drugs to reduce the severity of this global pandemic ” He said, ‘The chemical compound we are developing will prevent the virus from entering the cells.’
Janetka said the goal of the study is to develop the molecules into an inhibitor that can be taken by mouth and could become an effective part of anti-Covid-19 drug inhibitors.
